Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Lackner, H; Sovinz, P; Benesch, M; Schwinger, W; Dornbusch, HJ; Moser, A; Triebl-Roth, K; Urban, C.
Immunosuppressive treatment in alopecia universalis. Prednisolone, cyclosporine A, and tacrolimus in a 4 year old boy
MONATSSCHR KINDERHEILK. 2007; 155: S54-S57. Doi: 10.1007/s00112-005-1245-8
Web of Science FullText FullText_MUG

Leading authors Med Uni Graz: Lackner Herwig
Co-authors Med Uni Graz: Benesch Martin; Dornbusch Hans Jürgen; Ritter-Sovinz Petra; Schwinger Wolfgang; Urban Ernst-Christian
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: Alopecia universalis is characterized by total loss of body hair and can occur at any age, causing significant psychological morbidity in most cases. Though there is evidence to suggest that alopecia universalis is an autoimmune disease, the cause of the disease is still not known with certainty. Spontaneous recovery is unusual (<10%), and the long-term prognosis in cases not responding to therapy is poor, despite the variety of therapies available. Experience of immunosuppressive treatment in children with alopecia universalis is limited. We report on a 4-year-old boy, who was successfully treated for refractory alopecia universalis with prednisolone and cyclosporine A by mouth combined with topical application of tacrolimus. Our case report shows that systemic immunosuppression may be a promising treatment option for some children with alopecia universalis who are badly distressed by their condition. However, potential treatment-related risks have to be weighed against the psychosocial stress experienced by these patients and their families.
Find related publications in this database (Keywords): Alopecia universalis; systemic immunosuppressive; therapy children